326
S. D. Bull et al. / Tetrahedron: Asymmetry 9 (1998) 321–327
3.8. (3S)-3-Isopropyl-2-methoxy-5-oxo-3,4,5,6-tetrahydropyrazine 6
Rf 0.25 (EtOAc). M.p. 138°C (Dec). [α]2D3 +8.5 (c 1.0 in H2O). IR (KBr) 3264 (NH), 2948 (CH),
1699 (C_N), 1680 (C_O), 1649 (NH). 1H NMR (CD3OD) δ: 0.82 (3H, d, J 6.9, CH(CH3)2), 1.08 (3H,
d, J 6.9, CH(CH3)2), 2.33 (1H, m, CH(CH3)2), 3.74 (3H, s, OMe), 3.88 (1H, m, H3), 3.92 (2H, JAB
1
17.4, JAX 2.5, δAB 0.03, 2×H6). H NMR NOE, 2×0.4% enhancement between δ 3.74 to δ 0.82 and
δ 3.74 to δ 1.08. 13C NMR (CD3OD) δ: 15.6 (CH(CH3)2), 17.4 (CH(CH3)2), 32.4 (CH(CH3)2), 48.8
(OMe), 52.1 (C6), 57.9 (C3), 161.8 (C2), 172.4 (C5). HRMS for C8H15N2O2 (M+1)+, calcd 171.1139,
found 171.1133.
3.9. H2N-L-Val-Gly-OH 7
Compound 5 was dissolved in 2 M HCl for 12 hours and the solvent removed under vacuum to afford,
after treatment with epoxypropane, 7 in quantitative yield. This compound was identical to material
obtained from treating dipeptide 3 with 2 M HCl. [α]2D3 +94.8 (c 2.0 in H2O), m.p 253°C [lit.10 m.p
258°C, [α]2D3 +101.5 (c 2.0 in H2O)]. This compares with literature data for NH2-Gly-L-Val-OH [lit.10
m.p. 248°C, [α]2D3 −20.2 (c 2.0 in H2O)].
3.10. (3S)-3,6-Dihydro-2,5-dimethoxy-3-isopropyl-pyrazine 1
Me3O·BF4 (135 g, 915 mmol) and DKP 4 (50 g, 320 mmol) were efficiently mixed together, as
solids, then covered with dichloromethane (500 ml) under an atmosphere of nitrogen. After 24 hours
the heterogeneous reaction mixture was stirred vigorously using a mechanical stirrer. After a further 48
1
hours a small portion of the lower phase was removed and H NMR spectral analysis carried out to
determine whether any 5 or 6 was remaining. An extra equivalent of Me3O·BF4 (35 g) was then added if
required and the reaction mixture stirred for a further 24 hours. The biphasic reaction mixture was then
poured slowly, with rapid stirring and cooling, into a saturated solution of sodium bicarbonate (750 ml)
[caution — effervescence], ensuring that the solution remained above pH 7.5 at all times by the addition
of solid bicarbonate. The biphasic solution was extracted with dichloromethane (2×200 ml), filtered
through Celite®, the organic layers dried (MgSO4), and concentrated in vacuum to afford 1 (45 g, 245
mmol) as a pale yellow oil. [α]2D3 +108.9 (c 1.0 in EtOH) [lit.2 [α]2D3 +106.3 (c 1.0 in EtOH)]; 1H NMR
(CDCl3) δ: 0.77 (3H, d, J 6.9, CH(CH3)2), 1.04 (3H, d, J 6.9, CH(CH3)2), 2.23 (1H, m, CH(CH3)2),
3.69 (3H, s, OMe), 3.73 (3H, s, OMe), 3.90 (3H, m, H3 and 2×H6). 13C NMR (CDCl3) 16.8, 18.9
(2×CH(CH3)2), 32.3 (CH(CH3)2), 46.4 (C6), 52.3 (OCH3), 52.34 (OCH3), 60.8 (C3), 162.2, 164.7 (C2
and C5). MS: m/z 185 (M+1)+.
Acknowledgements
Under the LINK Asymmetric Synthesis Programme, financial support for this work is gratefully
acknowledged from the EPSRC, DTI and Zeneca Pharmaceuticals.
References
1. R. M. Williams, Synthesis of Optically Active α-Amino Acids, Pergamon Press, 1989; H. Heimgartner, Angew. Chem. Int.
Ed. Engl., 1991, 30, 238; R. O. Duthaler, Tetrahedron, 1994, 50, 1539; D. Seebach, A. R. Sting, M. Hoffmann, Angew.